Myfortic Magasýruþolin tafla 180 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 180 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 180 mg

Myfortic Magasýruþolin tafla 360 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

myfortic magasýruþolin tafla 360 mg

novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 360 mg

Timosan Depot í stakskammtaíláti Augnhlaup í stakskammtaíláti 1 mg/g আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

timosan depot í stakskammtaíláti augnhlaup í stakskammtaíláti 1 mg/g

santen oy* - timololum maleat - augnhlaup í stakskammtaíláti - 1 mg/g

Syntocinon (Syntocinon 40 a.e./ml) Nefúði, lausn 6,7 míkróg/skammt আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

syntocinon (syntocinon 40 a.e./ml) nefúði, lausn 6,7 míkróg/skammt

alfasigma s.p.a. - oxytocinum inn - nefúði, lausn - 6,7 míkróg/skammt

Syntocinon Stungulyf, lausn 10 a.e./ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

syntocinon stungulyf, lausn 10 a.e./ml

alfasigma s.p.a. - oxytocinum inn - stungulyf, lausn - 10 a.e./ml

Azarga ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

azarga

novartis europharm limited - skammtar, notkunar í augu. maleat - glaucoma, open-angle; ocular hypertension - augnlækningar - minnkuð augnþrýstingur (iop) hjá fullorðnum sjúklingum með gláku í augnlokum eða augnháþrýstingi, sem einlyfjameðferð veldur ófullnægjandi blóðsykursfalli.

Izba ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

izba

novartis europharm limited - travoprost - ocular hypertension; glaucoma, open-angle - ophthalmologicals, antiglaucoma preparations and miotics - minnkun á hækkun á augnþrýstingi hjá fullorðnum sjúklingum með háþrýsting í hálsi eða augnháðum gláku (sjá kafla 5. lækkun hækkað í auga þrýsting í börn sjúklinga á aldrinum 3 ár að < 18 ára með augu háan blóðþrýsting eða börn gláku.

Vipdomet ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

vipdomet

takeda pharma a/s - rannsóknir á dýra, kvarta stutt og long-term - sykursýki, tegund 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. þrefaldur samsetning meðferð) sem viðbót til að fæði og æfa til að bæta blóðsykursstjórnun í sjúklinga þegar insúlín í stöðugu skammtur og kvarta einn veita ekki fullnægjandi blóðsykursstjórnun.

Ciprofloxacin Alvogen (Ciprofloxacin Portfarma) Filmuhúðuð tafla 500 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

ciprofloxacin alvogen (ciprofloxacin portfarma) filmuhúðuð tafla 500 mg

alvogen ehf. - ciprofloxacinum hýdróklóríð - filmuhúðuð tafla - 500 mg

Fem-Mono Retard Forðatafla 60 mg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

fem-mono retard forðatafla 60 mg

viatris limited - isosorbidi mononitras inn - forðatafla - 60 mg